Kindeva Drug Delivery
We're hiring — explore open roles below and apply in a few clicks.
Location
Headquarters: Saint Paul, Minnesota, United States, North America
Region: Minnesota
Country: US
Continent: North America
About
Kindeva is a drug delivery CDMO specializing in drug-device combinations, offering development, manufacturing, analytical, fill-finish, regulatory, and post-commercialization capabilities. With expertise in injectable, inhalation, and dermal delivery, the company operates globally through multiple facilities, including Bridgeton and other sites in the United States and the United Kingdom. Kindeva emphasizes patient safety and quality in aseptic manufacturing and aims to accelerate product journeys from development to commercial manufacture. The organization traces its history back to innovations in autoinjectors, nasal and inhalation devices, and sustainable propellants, positioning itself as a strategic partner for advancing pharmaceutical products toward healthier tomorrows.
Kindeva Drug Delivery is a contract development and manufacturing organization (CDMO) specializing in complex drug-device combinations. The company provides end-to-end services including formulation, analytical testing, and commercial manufacturing for injectable, inhalation, and dermal therapies. Its primary customers are pharmaceutical and biotechnology firms seeking to accelerate the developmen
Kindeva Drug Delivery L.P.
2020
for_profit
active
Industries
Primary Industry: Business Services
Categories
Funding & Financials
Grant
46900000
200m-1b
private
Investors
Founders
William Riker
Leadership
Technology Stack
Products
Sterile Injectable Manufacturing: Provides aseptic fill-finish and device manufacturing for sterile injectable drug products in vials, cartridges, and syringes.
Autoinjector Platforms: Designs and manufactures single- and dual-chamber autoinjectors for self-administered injectable therapies.
Microneedle Array Patch (MAP) Drug Delivery: Develops and manufactures microneedle array patches for intradermal delivery of vaccines, peptides, proteins, biologics, and small molecules.
Pulmonary and Nasal Drug Delivery Technologies: Provides development and manufacturing of inhalation and nasal drug delivery devices including pMDIs, DPIs, SMIs, nebulizers, and nasal sprays.
Transdermal and Intradermal Drug Delivery: Offers formulation, development, and manufacturing of transdermal patches and intradermal delivery systems for systemic drug administration through the skin.
Analytical Testing Services: Delivers comprehensive analytical testing including method development, stability studies, extractables and leachables, and container closure integrity testing.
Funding rounds
Grant · $41.96M · (2023-08-03) · Lead: Global Britain Investment Fund
Acquired · (2022-11-14)
Series Unknown · $5M · (2022-06-13)
